乳がん治療に光活性化「スマート爆弾」を活用 (Breast cancer treatment advances with light-activated ‘smart bomb’)

ad

2025-02-10 カリフォルニア大学リバーサイド校 (UCR)

カリフォルニア大学リバーサイド校とミシガン州立大学の研究チームは、光活性化による新しい乳がん治療法を開発しました。この方法では、シアニン-カルボラン塩と呼ばれる新しい光感受性化合物を使用し、マウス実験で転移性乳がん腫瘍を完全に消滅させることに成功しました。従来の光線力学的療法(PDT)と比較して、これらの化合物は体内から迅速に排出され、がん細胞にのみ蓄積されるため、副作用を最小限に抑えます。さらに、近赤外線で活性化できるため、従来のPDTでは治療が難しかった深部の腫瘍にも効果が期待されます。この技術により、がん細胞を正確に標的とし、健康な組織を損傷することなく効果的な治療が可能となります。

<関連情報>

次世代光増感剤: 転移性癌の優れた光線力学的治療のためのシアニン-カルボラン塩 Next-Generation Photosensitizers: Cyanine-Carborane Salts for Superior Photodynamic Therapy of Metastatic Cancer

Amir Roshanzadeh, Dr. Hyllana C. D. Medeiros, Dr. Christopher K. Herrera, Carson Malhado, Anton W. Tomich, Steven P. Fisher, Sergio O. Lovera, Dr. Matthew Bates …
Angewandte Chemie International Edition  Published: 22 January 2025
DOI:https://doi.org/10.1002/anie.202419759

Graphical Abstract

We report a multifaceted assessment of novel cyanine-carborane salts as potent photosensitizers for photodynamic therapy (PDT). These compounds exhibit efficient tumor targeting through uptake by organic anion-transporting polypeptides (OATP). Upon near-infrared (NIR) light irradiation, cyanine-carborane salts generate reactive oxygen species (ROS), triggering apoptosis and significantly suppressing tumor cell proliferation and migration. In vivo studies demonstrate anti-tumor activity with minimal systemic toxicity, highlighting their potential as next-generation PDT therapeutics.

乳がん治療に光活性化「スマート爆弾」を活用 (Breast cancer treatment advances with light-activated ‘smart bomb’)

Abstract

Photodynamic therapy (PDT) has emerged as a promising targeted treatment for cancer. However, current PDT is limited by low tissue penetration, insufficient phototoxicity (toxicity with light irradiation), and undesirable cytotoxicity (toxicity without light irradiation). Here, we report the discovery of cyanine-carborane salts as potent photosensitizers (PSs) that harness the near-infrared (NIR) absorbing [cyanine+] with the inertness of [carborane]. The implementation of [cyanine+] [carborane] salts dramatically enhance cancer targeting of the PSs and decrease cytotoxicity. We characterize the cellular uptake of the cyanine-carborane PSs, organelle localization, generation of reactive oxygen species (ROS) with the ability to cogenerate multiple ROS species, suppression of pro-metastatic pathways, and activation of apoptotic pathways. We further demonstrate the ability of optimized PSs to eliminate tumors in vivo using an orthotopic mouse model of breast cancer. These newly developed [cyanine+] [carborane] salt PSs introduce a potent therapeutic approach against aggressive breast cancer while decreasing side effects.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました